William Cromwell
Family Medicine · Raleigh, NCNPI 1699777565
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $710,290 of the $878,704 with a category attached, or 80.8%. 12 manufacturers reported payments, led by Esperion Therapeutics, Inc. at 37.4% of the total. Reporting peaked in 2019 at $227,417 and has fallen 78.1% since, to $49,866 in 2025. Among family medicine clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 820 payments — averaging $1071.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Esperion Therapeutics, Inc.$329K
- Amgen$298K
- Amarin Pharma, Inc.$237K
- Merck$6K
- Novartis$4K
- AstraZeneca$3K
- plus $2K from 6 others
Across 314 payments — averaging $5685.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$641K
- Seqirus USA Inc$453K
- AstraZeneca$346K
- Amgen$169K
- Currax Pharmaceuticals LLC$158K
- Sanofi US Services Inc.$18K
What the payments were for
- Consulting fees$13,1501%
- Speaking & faculty fees$710,29081%
- Travel & lodging$136,22816%
- Food & beverage$19,0062%
- Education$310%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Esperion Therapeutics, Inc. | 253 | $328,716 |
| Amgen | 264 | $298,234 |
| Amarin Pharma, Inc. | 267 | $236,656 |
| Merck | 5 | $6,206 |
| Novartis | 2 | $3,536 |
| AstraZeneca | 12 | $3,249 |
| Modernatx, Inc. | 10 | $1,687 |
| Agepha Pharma FZ LLC | 1 | $183 |
| Astrazeneca UK Limited | 1 | $135 |
| Boston Scientific | 2 | $58 |
| Regeneron Healthcare Solutions, Inc. | 2 | $31 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$878,704 in reported general payments places this provider in the 95th percentile of 3,444 family medicine providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Repatha SureclickEvolocumab | 44 | $33,494 |
| VascepaIcosapent Ethyl | 11 | $11,209 |
| Ezetimibe | 35 | $937 |
| Rosuvastatin Calcium | 16 | $266 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Raleigh
- Scott BrundleRaleigh$25K
- Mohammad BalochRaleigh$16K
- Steve VacalisGastonia$693K
- David DundeeWinston Salem$633K
- Kevin SodenCharlotte$558K
- Brian ForrestApex$398K
- Joseph KonenCharlotte$322K
- Richard RachimaCharlotte$294K
- Dimitrios HondrosCharlotte$275K
- Domingo Rodriguez-CueGarner$253K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.